Posted inBiotechnology
Biogen ends Apellis research programs, cuts ‘small number’ of roles after $5.6B buyout
Biogen isn’t wasting any time integrating its multibillion-dollar purchase of Apellis, revealing plans to part ways with some of the biotech’s staffers…









